reports
Parks! America Addresses False FC Assertions
Parks! America Addresses False FC Assertions PINE MOUNTAIN, Georgia, May 07, 2024 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA) (“Parks! America” or the “Company”), a leading operator of regional safari parks in the United States. Dear Parks! America Shareholders, On April 23, 2024, we filed our proxy statement for the upcoming June 6, 2024 Parks! America, Inc. (“PRKA” or the “Company”) Annual Meeting of Stockholders, and the mailing of the proxy commenced on April 26, 2024. Please read the information in this proxy carefully and cast your votes thoughtfully. We strongly ...
INNOVATE Corp. Announces First Quarter 2024 Results
INNOVATE Corp. Announces First Quarter 2024 Results - Infrastructure: DBM Global achieved first quarter revenue of $307.9 million -- Life Sciences: R2 delivered record North America system sales in the first quarter 2024 -- Spectrum: Broadcasting's revenue growth driven by launch of new networks - NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the first quarter. Financial Summary (in millions, except per share amounts)Three Months Ended March 31, 2024 2023 Increase / (Decrease)Revenue$...
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended March 31, 2024. “This quarter, we implemented important decisions to maximize the value of our MRD and Immune Medicine businesses. I am confident in the steps we are taking to execute ...
Superior Group of Companies Reports First Quarter 2024 Results
Superior Group of Companies Reports First Quarter 2024 Results – Total net sales of $138.8 million up from $130.8 million in prior year first quarter –– Net income of $3.9 million up from $0.9 million in prior year first quarter –– EBITDA of $9.6 million up from $6.9 million in prior year first quarter –– Board of Directors approves $0.14 per share quarterly dividend –– Raises full-year outlook – ST. PETERSBURG, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its first quarter 2024 results. “The year is off to a str...
Solid Power First Quarter 2024 Results Reflect Continued Progress Towa...
Solid Power First Quarter 2024 Results Reflect Continued Progress Towards 2024 Goals Business, operational, and financial update call scheduled for 4:30 p.m. ET today LOUISVILLE, Colo., May 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SLDP), a leading developer of solid-state battery technology, today announced its operational and financial results for the first quarter of 2024. Recent Business Highlights Strong early execution on SK On line installation and technology transfer.Expanded electrolyte sampling with shipments to multiple potential customers.A-2 Sample cells remain on track with ...
BlackLine Announces First Quarter Financial Results
BlackLine Announces First Quarter Financial Results LOS ANGELES, May 07, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: BL), today announced financial results for the first quarter ended March 31, 2024. "BlackLine’s financial results this quarter exceeded our revenue and profitability expectations, demonstrating our ability to deliver profitable growth as we relentlessly drive our refreshed strategy and new operating model,” said Owen Ryan, co-CEO of BlackLine. “Though it is still early, we are seeing encouraging signs of progress across the company. Moving forward, we will look to capitaliz...
Flywire Reports First Quarter 2024 Financial Results
Flywire Reports First Quarter 2024 Financial Results First Quarter Revenue Increased 21% Year-over-Year First Quarter Revenue Less Ancillary Services Increased 24% Year-over-Year Company Provides Second Quarter and Fiscal-Year 2024 Outlook BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: FLYW) (“Flywire” or the “Company”) a global payments enablement and software company, today reported financial results for its first quarter ended March 31, 2024. "We are pleased with our 2024 first quarter results, where we signed more than 200 new clients, the highest the company has signe...
Cricut, Inc. Reports First Quarter 2024 Financial Results
Cricut, Inc. Reports First Quarter 2024 Financial Results Paid subscribers of approximately 2.8 million, up 3% over Q1 2023 Q1 2024 revenue of $167.4 million, 8% decline compared to Q1 2023 Delivered 21st consecutive quarter of profitability with net income of $19.6 million, up 116% over Q1 2023 Board authorizes three capital allocation items SOUTH JORDAN, Utah, May 07, 2024 (GLOBE NEWSWIRE) -- Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced financial results for it...
MidCap Financial Investment Corporation Reports Financial Results for ...
MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended March 31, 2024 Results for the Quarter Ended March 31, 2024 and Other Recent Highlights: Net investment income per share for the quarter was $0.44, compared to $0.46 for the quarter ended December 31, 2023 Net asset value per share as of the end of the quarter was $15.42, compared to $15.41 as of December 31, 2023 New investment commitments made during the quarter totaled $149 million(1) Gr...
Avid Bioservices to Participate at Upcoming Investor Conferences
Avid Bioservices to Participate at Upcoming Investor Conferences TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate at two upcoming investor conferences. Nick Green, president and chief executive officer, will be the featured speaker in a fireside chat at the RBC Capital Markets 20...
Runway Growth Finance Corp. Reports First Quarter 2024 Financial Resul...
Runway Growth Finance Corp. Reports First Quarter 2024 Financial Results Delivered Total and Net Investment Income of $40.0 million and $18.7 million, Respectively Investment Portfolio of $1.0 billion Chairman, President and CEO David Spreng Returns from Medical Leave Conference Call Today, Tuesday, May 7, 2024 at 5:00 p.m. ET MENLO PARK, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, tod...
PubMatic Announces Record First Quarter 2024 Financial Results
PubMatic Announces Record First Quarter 2024 Financial Results Revenue and adjusted EBITDA exceeded guidance; Delivered accelerated year-over-year revenue growth of 20%; Net loss of $(2.5) million or (4)% margin; Adjusted EBITDA of $15.1 million or 23% margin, more than double from Q1 2023; Supply Path Optimization represented 50% of total activity; Generated $24.3 million in cash from operating activities and tripled free cash flow over Q1 2023 to $16.3 million NO-HEADQUARTERS/REDWOOD CITY, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent techn...
Rapid7 Announces First Quarter 2024 Financial Results
Rapid7 Announces First Quarter 2024 Financial Results Annualized recurring revenue (“ARR”) of $807 million, an increase of 11% year-over-yearTotal revenue of $205 million, up 12% year-over-year; Product subscriptions revenue of $197 million, up 13% year-over-yearGAAP operating income of $11 million; Non-GAAP operating income of $40 millionNet cash provided by operating activities of $31 million; Free cash flow of $28 million BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (Nasdaq: RPD), a leader in extended risk and threat detection, today announced its financial results for th...
Gulf Island Reports First Quarter 2024 Results
Gulf Island Reports First Quarter 2024 Results THE WOODLANDS, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”), a leading steel fabricator and service provider to the industrial and energy sectors, today announced results for the first quarter 2024. FIRST QUARTER 2024 SUMMARY Consolidated revenue of $42.9 millionConsolidated net income of $6.2 million; Adjusted EBITDA of $3.7 millionServices Division operating income of $2.9 million; EBITDA of $3.3 millionFabrication Division operating income of $4.7 million; Adjusted...
Shoals Technologies Group, Inc. Reports Financial Results for First Qu...
Shoals Technologies Group, Inc. Reports Financial Results for First Quarter 2024 – Quarterly Revenue of $90.8 million –– Gross Margin of 40.2% –– Net Income of $4.8 million –– Adjusted EBITDA of $20.5 million –– Backlog and Awarded Orders Increased 17% Year-Over-Year to $615.2 million –– Provides Second Quarter and Full Year 2024 Outlook – PORTLAND, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a leading provider of electrical balance of system (“EBOS”) solutions for solar, battery storage, and electric vehicle chargin...
Aligos Therapeutics Reports Recent Business Progress and First Quarter...
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today reported recent business progress and financial results for the first quarter 2024. “We have executed on a number of key deliverables to position Aligos for success,” stated Lawrence Blatt, Ph.D., MBA, Chairman, President & CEO of Aligo...
SIGA Reports Financial Results for Three Months Ended March 31, 2024
SIGA Reports Financial Results for Three Months Ended March 31, 2024 Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 MillionCorporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2024. “SIGA delivered strong results in the first quarter, with product revenues of $24 million and pre-tax operating income of $11 million, both up over the comparable quarter in 2023,”...
scPharmaceuticals to Announce First Quarter 2024 Financial Results on ...
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024 Management to host conference call and webcast at 4:30 p.m. ET BURLINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Tuesday, May 14th, 2024, to discuss the financial results ...
Ocular Therapeutix™ Reports First Quarter 2024 Results
Ocular Therapeutix™ Reports First Quarter 2024 Results Recent Leadership Appointments Put Ocular on Track to Become a Leader in Retinal Care Site Activation and Patient Enrollment for AXPAXLI™ SOL-1 Phase 3 wet AMD Trial Progressing with First Subjects Randomized in April 2024 Cash Expected to Support Operations Into 2028, Based on $482.9M March 31, 2024, Cash Balance June 13, 2024, Investor Day to Outline Updated Corporate Strategy BEDFORD, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed t...
Savara to Present at the Citizens JMP Life Sciences Conference
LANGHORNE, Pa.--(BUSINESS WIRE)-- (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Citizens JMP Life Science Conference on May 14, 2024 at 6:00am PT/9:00am ET. A live webcast of the fireside chat will be available on Savara’s website at and will be archived for 90 days. About Savara Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.